STERIS Powers Into a Chemical-Free Future

STERIS invests RM75 million in electron-beam technology to deliver faster, chemical-free sterilization for the global medical device market

16 Apr 2026

STERIS is doubling down on the future of medical safety with its latest acquisition of Adventa’s electron-beam sterilization unit. This RM75 million deal signals a shift toward high-speed, chemical-free technology at a time when traditional methods face increasing scrutiny. By securing these assets, the company is positioning itself at the center of a cleaner and faster healthcare supply chain.

Modern healthcare manufacturers are moving away from legacy chemical processes that often involve toxic residues and long turnaround times. Electron-beam technology offers a high-voltage alternative, using electricity to neutralize pathogens in seconds. This method provides a significant efficiency boost for high-volume products like surgical kits and implants.

The timing of this expansion is crucial for a global market still wary of supply chain bottlenecks. Having more specialized centers allows medical providers to bypass the slow queues often found in older facilities. This translates to faster delivery times for hospitals and a more reliable flow of essential tools for surgeons.

Industry analysts expect electricity-powered sterilization to claim a larger share of the market as environmental regulations tighten. This move reflects a broader trend where technical performance must meet sustainability goals. STERIS is betting that the road to better patient outcomes is paved with faster, greener innovation.